Targeting Vascular Changes in Lesions in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

E-ISSN： 1875-6166|12|1|7-14

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.12, Iss.1, 2012-03, pp. : 7-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Osteopontin in Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 4, 2010-09 ,pp. : 249-256

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Inflammatory Immunotherapy for Multiple Sclerosis/Experimental Autoimmune Encephalomyelitis (EAE) Disease

Current Medicinal Chemistry, Vol. 12, Iss. 25, 2005-12 ,pp. : 2947-2962

Bentham Science Publishers

Access to resources Recommend Favorite

The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4453-4464

Bentham Science Publishers

Access to resources Recommend Favorite

Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 7, 2015-01 ,pp. : 915-935

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 5, 2012-08 ,pp. : 556-569

Bentham Science Publishers

Access to resources Recommend Favorite